Valuation: Kobayashi Pharmaceutical Co., Ltd.

Market Cap 426B 2.67B 2.32B 2.16B 1.99B 3.75B 255B 3.81B 25.53B 10B 127B 10.04B 9.82B P/E 2026 *
40.9x
P/E 2027 * 31.4x
Enterprise Value 360B 2.26B 1.96B 1.82B 1.68B 3.17B 216B 3.22B 21.58B 8.45B 107B 8.49B 8.3B EV / Sales 2026 *
2.09x
EV / Sales 2027 * 1.98x
Free-Float
64.46%
Yield 2026 *
1.85%
Yield 2027 * 1.91%
1 day-3.09%
1 week+2.19%
Current month+1.98%
1 month+2.41%
3 months-4.29%
6 months+3.25%
Current year+2.39%
1 week 5,440
Extreme 5440
5,879
1 month 5,396
Extreme 5396
5,879
Current year 5,251
Extreme 5251
6,140
1 year 5,030
Extreme 5030
6,140
3 years 4,700
Extreme 4700
7,933
5 years 4,700
Extreme 4700
10,470
10 years 4,340
Extreme 4340
13,120
Manager TitleAgeSince
Director of Finance/CFO - -
President 61 28/02/2025
Chief Tech/Sci/R&D Officer 51 30/06/2020
Director TitleAgeSince
Director/Board Member 55 31/05/2004
Director/Board Member 69 28/02/2022
Chairman 72 27/03/2025
Change 5-day change 1-year change 3-year change Capi.($)
-3.09%+2.19%+4.59%-28.91% 2.67B
-1.46%-2.05%-5.83%-7.96% 335B
-2.73%+6.76%-3.29%+2.07% 140B
-2.02%+1.69%+6.76%+21.13% 73.3B
-0.18%-2.64%-13.65%-17.81% 51.88B
-2.43%+2.17%-10.93%-20.86% 37.08B
+0.89%+6.21%-9.37%-52.96% 30.71B
-1.13%+3.91%-26.73%-32.20% 20.32B
-0.61%+1.28%+13.82%+4.91% 19.7B
-3.99%+0.84%-4.55%+20.33% 19.2B
Average -1.67%+3.12%-4.92%-11.23% 73.05B
Weighted average by Cap. -1.66%+2.40%-5.02%-6.02%

Financials

2026 *2027 *
Net sales 173B 1.08B 940M 873M 805M 1.52B 103B 1.54B 10.33B 4.05B 51.3B 4.06B 3.97B 180B 1.13B 980M 910M 839M 1.58B 108B 1.61B 10.77B 4.22B 53.47B 4.24B 4.14B
Net income 10.52B 65.97M 57.3M 53.21M 49.08M 92.44M 6.3B 94.12M 630M 247M 3.13B 248M 242M 13.67B 85.76M 74.49M 69.17M 63.79M 120M 8.19B 122M 819M 321M 4.07B 322M 315M
Net Debt -66B -414M -360M -334M -308M -580M -39.52B -591M -3.95B -1.55B -19.63B -1.55B -1.52B -70.23B -440M -383M -355M -328M -617M -42.05B -628M -4.21B -1.65B -20.88B -1.65B -1.62B
Logo Kobayashi Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the manufacture and sale of healthcare products, daily necessities, and products such as heat packs. The Company operates through two segments including domestic and international. Healthcare products include anmerutsu, eyebon, inochinohaha, naishitoru, and oral hygiene products. Daily necessities include air fresheners/deodorizers, sundries, and food products. The Company also engages in transportation services, the manufacture and sale of synthetic resin containers, real estate management, and advertising planning and production.
Employees
3,731
Date Price Change Volume
31/07/26 JP¥5,558.00 -3.09% 117,800
30/07/26 JP¥5,735.00 -2.37% 856,900
29/07/26 JP¥5,874.00 +3.98% 289,600
28/07/26 JP¥5,649.00 +1.11% 217,800
27/07/26 JP¥5,587.00 +2.72% 207,100
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
5,735.00JPY
Average target price
5,496.25JPY
Spread / Average Target
-4.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4967 Stock